(Q74400700)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

editorial

0 references

title

Infliximab therapy for ulcerative colitis: many unanswered questions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Present DH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

2294-2296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04031.X

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04031.X

Infliximab in Crohn's disease: first anniversary clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04031.X

Clinical experience with infliximab therapy in 100 patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04031.X

Infliximab for refractory ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04031.X

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04031.X

10.1111/J.1572-0241.2001.04031.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513164%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference